HORN HOWARD (Chief Financial Officer) received a stock award from ULTRAGENYX PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/20/2026ACC: 0001193125-26-164247
Officer· Chief Financial Officer
Since Mar 2026
+94.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
94.63K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34.67K
Price / share
—
Trade value
—
% of position
43.2%
4/16/2026
80.35K→115.03K
Total
Net shares
+34.67K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2026 | A · Award | +34.67K | — | — | 43.2% | 80.35K | 115.03K |
| Total | +34.67K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
59.95K shares
Shares
+59.95K
Strike price
24.52
Held after
59.95K
Exercisable
—
4/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock59.95K shares | 4/16/2026 | A · Award | +59.95K | 24.52 | — | 59.95K |